# A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

> clinical trial · VERIFIED · 2026-07-22

Status: RECRUITING · Sponsor: Seagen, a wholly owned subsidiary of Pfizer · Condition: Urothelial Carcinoma

- Company: Seagen, a wholly owned subsidiary of Pfizer
- Sector: Urothelial Carcinoma
- Primary source: https://clinicaltrials.gov/study/NCT04879329

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.